Chronic Kidney Disease News

A group of experts, patients and caregivers proposed recommendations to improve clinical care of pediatric patients with chronic kidney disease in a special report published in the American Journal of Kidney Disease.

Intra-dialysis multicomponent yoga is a feasible and safe form of relaxation and exercise among patients on maintenance dialysis, according to data published in Kidney International Reports.

Mineralocorticoid receptor antagonists disrupt the renin-angiotensin-aldosterone system and provide beneficial outcomes in several renin-angiotensin-aldosterone system-mediated disease states.

Best diabetes medical treatment was just as effective in albuminuria remission as Roux-en-Y gastric bypass for adults with diabetic kidney disease and obesity, according to study results published in eClinical Medicine.

In this video, Paula LeClair, MBA, MHCDS, U.S. general manager at Healthy.io and chairperson for the American Diabetes Association Board in New England, discusses how the Minuteful Kidney test can improve screening adherence for chronic kidney disease.

ORLANDO — Using a real-time potassium monitoring device in patients on hemodialysis saves more money than the usual care and increases quality of life, according to a presenter at ASN Kidney Week.

New-onset chronic kidney disease among U.S. adults with diabetes was highest among racial and ethnic minorities compared with white individuals, according to findings published in The New England Journal of Medicine.

ORLANDO — In this video from ASN Kidney Week, Jula Inrig, MD, chief medical officer of Travere Therapeutics Inc., discusses the use of dapagliflozin with sparsentan as treatment for IgA nephropathy and focal segmental glomerulosclerosis.

Sarcopenic obesity may increase the risk for chronic kidney disease among adults with type 2 diabetes, but low muscle mass without obesity was not associated with CKD, according to study results published in Obesity.

PHILADELPHIA — Half of patients with systemic lupus erythematosus and new-onset, low-grade proteinuria progress to clinical proteinuria within 2 years, according to results of a study presented at ACR Convergence 2022.